0001493152-18-009890.txt : 20180711
0001493152-18-009890.hdr.sgml : 20180711
20180711061027
ACCESSION NUMBER: 0001493152-18-009890
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20180711
DATE AS OF CHANGE: 20180711
EFFECTIVENESS DATE: 20180711
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Virtual Crypto Technologies, Inc.
CENTRAL INDEX KEY: 0000797542
STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770]
IRS NUMBER: 680080601
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-316474
FILM NUMBER: 18947993
BUSINESS ADDRESS:
STREET 1: 11 HA'AMAL STREET
CITY: TEL AVIV
STATE: L3
ZIP: 4809174
BUSINESS PHONE: 972 3-6003375
MAIL ADDRESS:
STREET 1: 11 HA'AMAL STREET
CITY: TEL AVIV
STATE: L3
ZIP: 4809174
FORMER COMPANY:
FORMER CONFORMED NAME: Emerald Medical Applications Corp.
DATE OF NAME CHANGE: 20151006
FORMER COMPANY:
FORMER CONFORMED NAME: ZAXIS INTERNATIONAL INC
DATE OF NAME CHANGE: 19950916
FORMER COMPANY:
FORMER CONFORMED NAME: INFERGENE CO
DATE OF NAME CHANGE: 19920703
D
1
primary_doc.xml
X0708
D
LIVE
0000797542
Virtual Crypto Technologies, Inc.
11 HA'AMAL STREET
TEL AVIV
L3
ISRAEL
4809174
+972 3-600-3375
DELAWARE
None
Emerald Medical Applications Corp.
ZAXIS INTERNATIONAL INC
INFERGENE CO
Corporation
true
Alon
Dayan
Shir Hashirim 39
Elakana
L3
ISRAEL
4481400
Executive Officer
Director
CEO
Gadi
Levin
Moshav Azriel 108
Lev Hasharon
L3
ISRAEL
45825
Executive Officer
CFO
Ben-Ami
Eyal
22 Ma'agal Shalom Street
Rishon Lezion
L3
ISRAEL
75770
Director
Other
Decline to Disclose
- 06b
false
2018-01-24
false
true
true
false
0
N/A
0
Unknown
0
UNKNOWN
UNKNOWN
XX
Unknown
None
AZ
ARIZONA
CA
CALIFORNIA
FL
FLORIDA
KS
KANSAS
MN
MINNESOTA
NJ
NEW JERSEY
NY
NEW YORK
RI
RHODE ISLAND
false
308555
308555
0
false
12
0
0
0
Some proceeds to be used for general working capital purposes may include salaries and payments to officers and/or directors listed in Item 3 of this Form D.
true
Virtual Crypto Technologies, Inc.
/s/ Gadi Levin
Gadi Levin
CFO
2018-07-11